Literature DB >> 17786420

Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.

Armando Luis Negri1, Rodolfo Spivacow, Elisa Del Valle, Irene Pinduli, Alicia Marino, Erich Fradinger, Jose Ruben Zanchetta.   

Abstract

The purpose of the present study was to compare the clinical characteristics of "pure" uric acid (UA) stone formers with that of "pure" calcium oxalate (CaOx) stone formers and to determine whether renal handling of UA, urinary pH, and urinary excretion of promoters and inhibitors of stone formation were different between the two groups. Study subjects comprised 59 patients identified by records of stone analysis: 30 of them had "pure" UA stones and 29 had "pure" CaOx nephrolithiasis. Both groups underwent full outpatient evaluation of stone risk analysis that included renal handling of UA and urinary pH. Compared to CaOx stone formers, UA stone formers were older (53.3 +/- 11.8 years vs. 44.5 +/- 10.0 years; P = 0.003); they had higher mean weight (88.6 +/- 12.5 kg vs. 78.0 +/- 11.0 kg; P = 0.001) and body mass index (29.5 +/- 4.2 kg/m(2) vs. 26.3 +/- 3.5 kg/m(2); P = 0.002) with a greater proportion of obese subjects (43.3% vs. 16.1%; P = 0.01). Patients with "pure" UA lithiasis had significantly lower UA clearance, UA fractional excretion, and UA/creatinine ratio, with significantly higher serum UA. The mean urinary pH was significantly lower in UA stone formers compared to CaOx stone formers (5.17 +/- 0.20 vs. 5.93 +/- 0.42; P < 0.0001). Patients with CaOx stones were a decade younger, having higher 24-h urinary calcium excretion (218.5 +/- 56.3 mg/24 h vs. 181.3 +/- 57.1 mg/24 h; P = 0.01) and a higher activity product index for CaOx [AP (CaOx) index]. Overweight/obesity and older age associated with low urine pH were the principal characteristic of "pure" UA stone formers. Impairment in urate excretion associated with increased serum UA was also another characteristic of UA stone formers that resembles patients with primary gout. Patients with pure CaOx stones were younger; they had a low proportion of obese subjects, a higher urinary calcium excretion, and a higher AP index for CaOx.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786420     DOI: 10.1007/s00240-007-0109-1

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  24 in total

1.  Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism.

Authors:  N A Breslau; L Brinkley; K D Hill; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

2.  [Obesity as one of the risk factors for urolithiasis].

Authors:  S Nishio; M Yokoyama; H Iwata; M Takeuchi; O Kamei; T Sugamoto; Y Seike; K Ochi; M Kin; K Aoki; S Nabeshima; H Takeda; S Takei
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1998-06

3.  Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition.

Authors:  N S Mandel; G S Mandel
Journal:  J Urol       Date:  1989-12       Impact factor: 7.450

4.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

5.  The estimation of citrate in serum and urine using a citrate lyase technique.

Authors:  S G Welshman; H McCambridge
Journal:  Clin Chim Acta       Date:  1973-07-14       Impact factor: 3.786

6.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 7.  Epidemiology and medical management of stone disease.

Authors:  H-G Tiselius
Journal:  BJU Int       Date:  2003-05       Impact factor: 5.588

8.  Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.

Authors:  H Yki-Järvinen; M R Taskinen
Journal:  Diabetes       Date:  1988-09       Impact factor: 9.461

9.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

10.  Obesity, weight gain, and the risk of kidney stones.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

View more
  11 in total

1.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

2.  Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.

Authors:  Boyd R Viers; John C Lieske; Terri J Vrtiska; Loren P Herrera Hernandez; Lisa E Vaughan; Ramilia A Mehta; Eric J Bergstralh; Andrew D Rule; David R Holmes; Amy E Krambeck
Journal:  Urology       Date:  2015-02-11       Impact factor: 2.649

3.  Metabolic diagnosis in stone formers in relation to body mass index.

Authors:  Elisa Elena Del Valle; Armando Luis Negri; Francisco Rodolfo Spivacow; Gabriela Rosende; Mariano Forrester; Irene Pinduli
Journal:  Urol Res       Date:  2011-06-10

4.  Biochemical and dietary factors of uric acid stone formation.

Authors:  Alberto Trinchieri; Emanuele Montanari
Journal:  Urolithiasis       Date:  2017-02-28       Impact factor: 3.436

5.  Biochemical diagnosis in 3040 kidney stone formers in Argentina.

Authors:  Francisco Rodolfo Spivacow; Elisa Elena del Valle; Armando Luis Negri; Erich Fradinger; Anabella Abib; Paula Rey
Journal:  Urolithiasis       Date:  2015-05-10       Impact factor: 3.436

6.  UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Authors:  Naeem Bhojani; Jennifer Bjazevic; Brendan Wallace; Linda Lee; Kamaljot S Kaler; Marie Dion; Andrea Cowan; Nabil Sultan; Ben H Chew; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

7.  Calcium oxalate stone and gout.

Authors:  Y M Fazil Marickar
Journal:  Urol Res       Date:  2009-09-25

8.  Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites.

Authors:  Jie Gao; Jun-Fa Xue; Meng Xu; Bao-Song Gui; Feng-Xin Wang; Jian-Ming Ouyang
Journal:  Int J Nanomedicine       Date:  2014-09-16

9.  The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Authors:  Yoshimi Tanaka; Shingo Hatakeyama; Toshikazu Tanaka; Hayato Yamamoto; Takuma Narita; Itsuto Hamano; Teppei Matsumoto; Osamu Soma; Teppei Okamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Ippei Takahashi; Shigeyuki Nakaji; Yuriko Terayama; Tomihisa Funyu; Chikara Ohyama
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 10.  Association of serum uric acid concentration with components of pediatric metabolic syndrome: A systematic review and meta-analysis.

Authors:  Parvin Goli; Roya Riahi; Seyede Shahrbanoo Daniali; Mohammadali Pourmirzaei; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2020-04-13       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.